🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
The goal of this single-arm, Phase II interventional clinical trial is to t...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2023-07-01
Trial ID
NCT05978609
Treatments Being Tested
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
This is a global, multicenter, randomized, open-label, Phase 2/3 study of D...
Status
Recruiting
Location
Research Site
Start Date
2025-09-26
Trial ID
NCT07129993
Treatments Being Tested
Study Design： Adjuvant gemcitabine therapy has been shown to improve recurr...
Status
Completed
Location
Chang-Gung Memorial Hospital
Start Date
2009-02
Trial ID
NCT00994721
RATIONALE: Pemetrexed disodium may stop the growth of tumor cells by blocki...
Status
Terminated
Location
University of Michigan Comprehensive Cancer Center
Start Date
2006-05
Trial ID
NCT00438204
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Institut Jules Bordet
Start Date
1999-07
Trial ID
NCT00004884
Treatments Being Tested
This is a study to look at whether the presence of circulating tumour DNA (...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2022-03-28
Trial ID
NCT04966663
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
Multicenter, prospective, open-labeled, 2-arm, non-comparative randomized p...
Status
Completed
Location
Institut Bergonié
Start Date
2022-02-09
Trial ID
NCT04807816
Treatments Being Tested